Iterum Therapeutics Reports First Quarter 2022 Financial Results
-General Alignment with FDA on Key Aspects of Design of Proposed Additional Clinical Trial- -Cash Runway into 2024- DUBLIN, Ireland and...
Month: May 2022
ProMIS Neurosciences Announces First Quarter 2022 Results
TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or...
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
FDA approval for EPSOLAY® (benzoyl peroxide, cream, 5%) represents Sol-Gel’s second approved product within less than a year; EPSOLAY is...
Humacyte First Quarter 2022 Financial Results and Business Update
-- Human Acellular Vessels™ (HAVs™) shipped to six hospitals in Ukraine for treatment of civilian and military vascular trauma injuries...
ProMIS Holds Annual and Special Meeting of Shareholders All Resolutions Approved
TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or...
FindThisBest Selects Tauri-Gum as The #1 Best Kosher Chewing Gum in the Overall Marketplace
Tauriga Sciences, Inc. Top 3 Finishers - FindThisBest Kosher Chewing Gum ReviewNEW YORK, NY, May 13, 2022 (GLOBE NEWSWIRE) --...
Marker Therapeutics Reports Q1 2022 Operating and Financial Results
Topline readout of Phase 2 AML trial Group 2 active disease anticipated in Q2 2022 Company plans to file INDs...
Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business Update
Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq:...
PLx Pharma Inc. Reports First Quarter 2022 Results and Provides Business Update
BUILDING A SOLID BASE OF VAZALORE® USERS Total Net Sales of $2.1 Million in the First Quarter of 2022, an...
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
Product demonstrations and educational presentations underscore the company’s leadership in advancing care for patients with benign prostatic hyperplasia (BPH)WAYNE, Pa.,...
Smart for Life Executes Letter of Intent with Diamond Creek Capital for $4 Million Senior Credit Facility
Proceeds Principally Allocated to Company’s Anticipated Acquisition of Ceautamed Worldwide, LLCMIAMI, May 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...
Qualigen Therapeutics, Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on...
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2022
TOKYO, Japan and CAMBRIDGE, United Kingdom, May 13, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) provides...
Addex Announces Participation in the 22nd Bio€quity Europe Conference
Geneva, Switzerland, May 13, 2022 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug...
Plantable Health Inc. Announces March 2022 First Quarter Financial Results
New York, New York--(Newsfile Corp. - May 13, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the...
Harvest One Announces Supply Agreement with Canopy Growth’s Spectrum Therapeutics’ Online Medical Store
Products to be Supplied via an Extension of the Company's Licensing Agreement with The Valens CompanyVancouver, British Columbia--(Newsfile Corp. -...
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
NEW YORK--(BUSINESS WIRE)--$LUCD #Biotech--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid...
Invitation to Conference Call Regarding Promore Pharma’s Interim Report for the First Quarter 2022
STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 13 May 2022 - Promore Pharma AB (publ)...
Sibannac to Acquire NOHO Brand Assets in Blockbuster Three-Way Deal
Scottsdale, Arizona--(Newsfile Corp. - May 12, 2022) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
NOHO, Inc. Enters Letter of Intent to Acquire Smog Armor(R), Inc. and Transfer NOHO Brand Assets to Sibannac, Inc. in Blockbuster Three-Way Deal
Scottsdale, Arizona--(Newsfile Corp. - May 12, 2022) - NOHO, Inc. (OTC Pink: DRNK), a Wyoming corporation (the "Company"), announced the...